Abstract
Background & context: Breast cancer is the most common type of malignancy in Cypriot women, with approximately 600 new cases diagnosed each year. Approximately 5 to 10% of these diagnoses are a result of a mutation in the BRCA 1/2 genes. Genetic testing for breast cancer predisposition has been available in the clinical practice for more than 20 years now. Since genetic information disclosure, following this type of tests, involves a language of possibilities and not certainties, complex distress issues may occur.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
